c-Jun is known to involve in aggressive tumor phenotype and metastasis in many cancers [43, 45, 46] and c-myc is also shown to increase the expression of Cyclin D1 and decrease expression of p21, p27 and p53 leading to proliferative advantage of cancer cells [47–49]. Here, TP53 is linked to cancer.